Navigation Links
InterMune Sells Danoprevir Rights to Roche for $175 Million
Date:10/6/2010

BRISBANE, Calif., Oct. 6 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN) today announced that it has sold worldwide development and commercialization rights to danoprevir (also known as RG7227 or ITMN-191) to Hoffman-La Roche Inc. and F. Hoffman-La Roche Ltd. for $175 million in cash.  In connection with this transaction, the collaboration agreement that InterMune and Roche entered into in October 2006 has been terminated.  In addition, the companies are actively exploring ways to continue their ongoing work together on other HCV research programs.  InterMune noted that as a result of this transaction, the company will make no further investment in danoprevir and that, including net proceeds from the transaction, it currently expects to have a cash balance of approximately $290 million at the end of 2010.

Dan Welch, Chairman, Chief Executive Officer and President of InterMune said, "After conducting a careful review of our strategy and financial position, we have decided to divest our rights to danoprevir to Roche.  This transaction provides a very substantial non-dilutive cash infusion that allows us to continue to independently and aggressively pursue the registration and commercialization of pirfenidone in the US and EU, and eliminates our obligation to make significant ongoing investments related to the further development and commercialization of danoprevir.  We are now in a very strong financial position that provides us with the resources and flexibility to maximize the value of pirfenidone, our largest and nearest-term value creation opportunity."

Conference Call and Webcast Details

InterMune will host a conference call today at 4:30 p.m. EDT to discuss the transaction.  Interested investors and others may participate in the conference call by dialing 866-408-9480 (U.S.) or 706-643-9223 (international), con
'/>"/>

SOURCE InterMune, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. InterMune to Present at 2010 Citi Health Care Conference
2. InterMune Receives FDA Complete Response Letter on Esbriet(TM) (Pirfenidone) New Drug Application
3. InterMune to Release First Quarter Financial Results on April 29
4. InterMune Announces Submission of MAA for Pirfenidone for the Treatment of Patients With IPF
5. InterMune Announces Proposed Public Offering of Common Stock
6. InterMune to Release Third Quarter Financial Results on November 5
7. InterMune Announces Collaboration With National Jewish Health on NIH-Supported Genetic Research in Idiopathic Pulmonary Fibrosis
8. InterMune to Present at Canaccord Adams Conference
9. InterMune Reports Second Quarter 2009 Financial Results and Business Highlights
10. InterMune to Release Second Quarter Financial Results on August 6
11. InterMune to Present at Goldman Sachs Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... Yuma Regional Cancer Center Officially ... brings comprehensive cancer care to Yuma, Arizona. , ... Center has officially opened. A Mayo Clinic Care ... such as open, semi-private and private infusion rooms, ... Resource Center, hematology, rehabilitation center, a pain management ...
(Date:7/30/2014)... 2014  AtheroNova Inc. (OTCBB: AHRO), a biotech ... compounds to safely regress atherosclerotic plaque and improve ... partner, CardioNova, has accomplished first dosing of subjects ... lead compound, AHRO-001.  This Phase 1b trial will ... safety trial completed in February 2014, in which ...
(Date:7/30/2014)... CA (PRWEB) July 30, 2014 Adding ... their weighing boat special – Buy 2 ... free. This promotion will benefit lab technicians looking for ... Weighing boats are ideal for multiple applications including weighing ... a variety of choices including diamond-shaped, hexagonal, square, aluminum ...
(Date:7/29/2014)... hurdled a number of significant technological challenges in ... technology originally created for the James Webb Space ... Harvey Moseley, a scientist at NASA,s Goddard Space ... electrostatically actuated microshutter arrays that is, those ... as functional as the current technology,s magnetically activated ...
Breaking Biology Technology:Sate-of-the-Art Yuma Regional Cancer Center Officially Opens 2AtheroNova Announces Milestone with Initiation of Phase 1b Clinical Trial of AHRO-001 2AtheroNova Announces Milestone with Initiation of Phase 1b Clinical Trial of AHRO-001 3AtheroNova Announces Milestone with Initiation of Phase 1b Clinical Trial of AHRO-001 4Weighing Boat Promotion Now Available at Pipette.com, Major Pipette Distributor 2Revolutionary microshutter technology hurdles significant challenges 2Revolutionary microshutter technology hurdles significant challenges 3Revolutionary microshutter technology hurdles significant challenges 4
... , , , , , , ... , , Features and benefits , ... , Suitable for a broad range of cell lines , ... and DNA Quantity vs. Transfection Efficiency ") , ...
... , , , For purification of up to 10 mg ultrapure plasmid , ... gravity-flow anion-exchange tips for efficient , purification of plasmid DNA , , ... Features and benefits , , ... to that obtained by 2x CsCl-gradient centrifugation , ...
... , , , , For ultrafast purification of up to 750 ... Features and benefits , , ... ultrapure DNA , ... No risk of DNA pellet loss during precipitation , ...
Cached Biology Technology:SuperFect Transfection Reagent 2SuperFect Transfection Reagent 3HiSpeed Plasmid Kits 2
(Date:7/29/2014)... the remote UK overseas territory of Ascension Island, one ... something of a renaissance. , Writing in the journal ... of Exeter and Ascension Island Government Conservation Department report ... remote South Atlantic outpost has increased by more than ... As many as 24,000 nests are now estimated to ...
(Date:7/29/2014)... (UM SOD) and Medicine (UM SOM) jointly announced ... million grant award from the National Institute of ... Institutes of Health to study the causes, prevention ... which renews a previous $12 million five-year NIAID-funded ... research by studying chlamydial and gonorrheal diseases as ...
(Date:7/29/2014)... of preterm babies latest research from the University ... teenagers, the brains of many preterm children can perform almost ... conducted by the University,s Robinson Research Institute has ... brain injury in early life, their cognitive abilities as a ... , However, the results of the study, published in this ...
Breaking Biology News(10 mins):Major turtle nesting beaches protected in 1 of the UK's far flung overseas territories 2University of Maryland Schools of Dentistry and Medicine receive NIH grant 2University of Maryland Schools of Dentistry and Medicine receive NIH grant 3University of Maryland Schools of Dentistry and Medicine receive NIH grant 4Preterm children's brains can catch up years later 2
... 18, 2014)-- Baylor University researchers, in collaboration with ... evidence of the environment inhabited by the early ... Island, Kenya. The groundbreaking discovery provides additional information ... connection between habitat preferences and the early diversification ...
... Glorioso, III, PhD (University of Pittsburgh School of Medicine, ... herpes viruses as efficient vectors for delivering therapeutic genes ... accomplishments, he has received a Pioneer Award from ... Ann Liebert, Inc., publishers. Human Gene Therapy ...
... lifelong debate of nature versus nurture continuesthis time in ... the Journal of Communication found that a ... children who engaged in increased viewing of violent TV ... Helen Vossen, and Patti Valkenburg of the University of ...
Cached Biology News:Discovery by Baylor University researchers sheds new light on the habitat of early apes 2Discovery by Baylor University researchers sheds new light on the habitat of early apes 3Joseph Glorioso, Ph.D., receives Pioneer Award 2Genetics linked to children viewing high amounts of violent media 2
Mouse monoclonal [AE3] to Cytokeratin 1 - 8, prediluted ( Abpromise for all tested applications). Antigen: Tissue / cell preparation - Human epidermal cells. Entrez GeneID: 140807 Swiss P...
Rac 1/2/3/4 (S-18)...
... K+ Cl- Cotransporter-1 (KCC1). ... significant sequence homology with ... REACTIVITIES: The immunogen sequence ... human, mouse, porcine and ...
Anti-G-alpha-i 1 G-Protein Host: mouse monoclonal Species Reactivity: human, mouse, rat Applications: WB Storage: 4C...
Biology Products: